Cargando…

Challenges and shifting paradigms in clinical trials in oncology: the case for immunological and targeted therapies

The advent of immunotherapy has undoubtedly changed the current standard for cancer treatment. Immunotherapy offers the possibility of achieving excellent results—a new alternative for patients with advanced-stage or relapsed disease. Nowadays, the progress made in tumour biology has led to multiple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sotelo-Rodríguez, Diana Carolina, Ruíz-Patiño, Alejandro, Ricaurte, Luisa, Arrieta, Oscar, Zatarain-Barrón, Zyanya Lucia, Cardona, Andrés F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695130/ https://www.ncbi.nlm.nih.gov/pubmed/31552109 http://dx.doi.org/10.3332/ecancer.2019.936

Ejemplares similares

Chronic and Severe Non-Lichenoid Oral Ulcers Induced by Nivolumab − Diagnostic and Therapeutic Challenge: A Case Report
por: Cardona, Andrés F., et al.
Publicado: (2020)

Refractory Bullous Pemphigoid in a Patient with Metastatic Lung Adenocarcinoma Treated with Pembrolizumab
por: Cardona, Andrés F., et al.
Publicado: (2021)

Comprehensive review of fetal adenocarcinoma of the lung
por: Ricaurte, Luisa María, et al.
Publicado: (2018)

When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review
por: Rodríguez, July, et al.
Publicado: (2021)

Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries
por: Cardona, Andrés F., et al.
Publicado: (2020)

Case Report: Differential Genomics and Evolution of a Meningeal Melanoma Treated With Ipilimumab and Nivolumab
por: Burgos, Remberto, et al.
Publicado: (2022)

Mortality and Advanced Support Requirement for Patients With Cancer With COVID-19: A Mathematical Dynamic Model for Latin America
por: Ruiz-Patiño, Alejandro, et al.
Publicado: (2020)

Atypical Skin Manifestations During Immune Checkpoint Blockage in Coronavirus Disease 2019–Infected Patients With Lung Cancer
por: Rolfo, Christian, et al.
Publicado: (2020)

Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non‐small cell lung cancer (AB‐CLICaP)
por: Ruiz‐Patiño, Alejandro, et al.
Publicado: (2020)

Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib
por: Cardona, Andrés F., et al.
Publicado: (2019)

Genotyping Squamous Cell Lung Carcinoma in Colombia (Geno1.1-CLICaP)
por: Cardona, Andrés F., et al.
Publicado: (2020)

Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP)
por: Cardona, Andrés F., et al.
Publicado: (2019)

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy
por: Barrón, Feliciano, et al.
Publicado: (2020)

KRAS and MET in non-small-cell lung cancer: two of the new kids on the ‘drivers’ block
por: Garcia-Robledo, Juan Esteban, et al.
Publicado: (2022)

Characteristics and outcomes of thymomas in Latin America: Results from over 10 years of experience (CLICaP‐LATimus)
por: Martín, Claudio, et al.
Publicado: (2021)

Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)
por: Ruiz‐Patiño, Alejandro, et al.
Publicado: (2019)

p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics
por: Ruiz-Patiño, Alejandro, et al.
Publicado: (2021)

Response rate of patients with baseline brain metastases from recently diagnosed non‐small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status
por: Arrieta, Oscar, et al.
Publicado: (2020)

Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses
por: Barrios-Bernal, Pedro, et al.
Publicado: (2022)

Scientific Productivity and Cancer-Related Mortality: A Case Study of a Positive Association in Colombia
por: Bravo-Linares, David, et al.
Publicado: (2019)

Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question
por: Ordóñez-Reyes, Camila, et al.
Publicado: (2022)

Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP)
por: Raez, Luis E., et al.
Publicado: (2022)

A Paradigm Shift in Radiation Oncology Training
por: Perni, Subha, et al.
Publicado: (2020)

Importancia pronóstica de las mutaciones del gen promotor de la transcriptasa inversa de la telomerasa en los meningiomas de alto grado
por: Cañas, Alejandro, et al.
Publicado: (2022)

Paradigm shift in head and neck oncology patient management
por: van Linden van den Heuvell, Chiquit, et al.
Publicado: (2017)

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study
por: Chamorro, Diego F., et al.
Publicado: (2023)

Overcoming TKI resistance in fusion-driven NSCLC: new generation inhibitors and rationale for combination strategies
por: Russo, Alessandro, et al.
Publicado: (2020)

The paradigm shift to precision oncology between political will and cultural acceptance
por: Rassy, E., et al.
Publicado: (2023)

Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID‐19 pandemic: the THOCOoP cooperative group
por: Arrieta, Oscar, et al.
Publicado: (2020)

Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country
por: Cifuentes, Claudia, et al.
Publicado: (2023)

Paradigm Shift or Shifting Paradigm for Type 1 Diabetes
por: Nakayama, Maki, et al.
Publicado: (2012)

Integration of artificial intelligence and precision oncology in Latin America
por: Sussman, Liliana, et al.
Publicado: (2022)

The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines
por: Wei, Jiao, et al.
Publicado: (2022)

Shifting Sugars and Shifting Paradigms
por: Siegal, Mark L.
Publicado: (2015)

Preface: genomics and biology of exercise is undergoing a paradigm shift
por: Eynon, Nir, et al.
Publicado: (2017)

Curcumin Pretreatment Prevents Potassium Dichromate-Induced Hepatotoxicity, Oxidative Stress, Decreased Respiratory Complex I Activity, and Membrane Permeability Transition Pore Opening
por: García-Niño, Wylly Ramsés, et al.
Publicado: (2013)

Paradigm shift in science with tackling global challenges
por: Li, Jinghai, et al.
Publicado: (2019)

A paradigm shift
Publicado: (2009)

Paradigm Shift to Neuroimmunomodulation for Translational Neuroprotection in Stroke
por: Amantea, Diana, et al.
Publicado: (2018)

Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine
por: Malenica, Ines, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2v1r69b8egifsci5ej9m48i57b